MetLife, Inc. $MET Shares Bought by Oregon Public Employees Retirement Fund

Oregon Public Employees Retirement Fund lifted its holdings in MetLife, Inc. (NYSE:MET) by 31.1% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 63,849 shares of the financial services provider’s stock after buying an additional 15,159 shares during the quarter. Oregon Public Employees Retirement Fund’s holdings in MetLife were worth $5,259,000 as of its most recent filing with the SEC.

A number of other institutional investors have also modified their holdings of the business. Norges Bank acquired a new position in MetLife in the second quarter valued at approximately $756,104,000. ABN AMRO Bank N.V. acquired a new stake in shares of MetLife during the 2nd quarter worth approximately $178,669,000. Amundi lifted its holdings in shares of MetLife by 40.2% in the 2nd quarter. Amundi now owns 4,507,362 shares of the financial services provider’s stock worth $361,265,000 after purchasing an additional 1,292,107 shares during the last quarter. Man Group plc boosted its position in MetLife by 325.5% during the 2nd quarter. Man Group plc now owns 1,344,551 shares of the financial services provider’s stock valued at $108,129,000 after purchasing an additional 1,028,554 shares during the period. Finally, Worldquant Millennium Advisors LLC boosted its position in MetLife by 1,028.2% during the 2nd quarter. Worldquant Millennium Advisors LLC now owns 856,905 shares of the financial services provider’s stock valued at $68,912,000 after purchasing an additional 780,955 shares during the period. Institutional investors own 94.99% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have weighed in on MET shares. Barclays set a $90.00 target price on MetLife in a research report on Thursday. Piper Sandler cut shares of MetLife from an “overweight” rating to a “neutral” rating and set a $84.00 price objective on the stock. in a report on Friday, September 19th. Wolfe Research raised shares of MetLife to a “strong-buy” rating in a research note on Tuesday, September 16th. UBS Group decreased their target price on shares of MetLife from $95.00 to $94.00 and set a “buy” rating for the company in a research report on Thursday. Finally, Keefe, Bruyette & Woods dropped their price target on shares of MetLife from $92.00 to $90.00 and set an “outperform” rating on the stock in a research note on Tuesday, November 11th. Two analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $95.08.

MetLife Stock Performance

MET stock opened at $79.37 on Friday. The company has a 50-day simple moving average of $78.77 and a 200 day simple moving average of $79.02. The company has a market capitalization of $52.30 billion, a P/E ratio of 14.95, a PEG ratio of 0.72 and a beta of 0.76. The company has a quick ratio of 0.18, a current ratio of 0.18 and a debt-to-equity ratio of 0.54. MetLife, Inc. has a fifty-two week low of $65.21 and a fifty-two week high of $88.09.

MetLife (NYSE:MET) last released its earnings results on Wednesday, November 5th. The financial services provider reported $2.37 EPS for the quarter, beating the consensus estimate of $2.30 by $0.07. MetLife had a net margin of 5.30% and a return on equity of 21.00%. The firm had revenue of $12.46 billion for the quarter, compared to analysts’ expectations of $18.64 billion. During the same quarter last year, the company earned $1.95 EPS. MetLife’s quarterly revenue was down 5.9% on a year-over-year basis. Sell-side analysts predict that MetLife, Inc. will post 9.65 earnings per share for the current fiscal year.

MetLife Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 10th. Investors of record on Tuesday, February 3rd will be issued a dividend of $0.5675 per share. The ex-dividend date of this dividend is Tuesday, February 3rd. This represents a $2.27 annualized dividend and a yield of 2.9%. MetLife’s payout ratio is presently 42.75%.

MetLife Company Profile

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.